MOH — authorised 23 March 2022
- Marketing authorisation holder: AAA USA NOVARTIS
- Status: likely_approved
🇮🇱 Pluvicto in Israel
MOH authorised Pluvicto on 23 March 2022
Marketing authorisation
Pluvicto in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Pluvicto approved in Israel?
Yes. MOH authorised it on 23 March 2022.
Who is the marketing authorisation holder for Pluvicto in Israel?
AAA USA NOVARTIS holds the Israeli marketing authorisation.